Nalbuphine Hydrochloride Injection, Solution
Product Images NDC 0409-1464

This is a prescription drug contained in 10 single-dose 1mL ampoules of nalbuphine HCI solution. Each ampoule contains 10mg of nalbuphine HCI, and buffers such as sodium citrate, dihydrate and citric acid, anhydrous. The solution is sterile and non-pyrogenic and can be used for intravenous, intramuscular or subcutaneous injection. The usual dosage can be found in the insert. The product must be protected from light and kept in the tray until it is ready to be used. Any unused portion should be discarded. This should be stored at a controlled temperature of 20 to 25°C. This is distributed by Hospira and has been approved by the USP.*

This is a prescription drug called Nalbuphine HCI Injection, with a strength of 20 mg/mL. The drug can be administered through intravenous, intramuscular, or subcutaneous routes. The package should be protected from light. The distributor is Hospira, Inc. based in Lake Forest, IL 60045 USA. The provided code includes a product identification number and a batch number.*

This is a prescription drug contained in a pack of 10 ampuls, each containing 1 mL of solution for intravenous, intramuscular or subcutaneous use. It has a NDC code of 0409-1465-01 and contains nalbuphine HCI, sodium citrate, dihydrate, citric acid, and sodium chloride as tonicity adjuster. The solution is sterile, non-pyrogenic, and the usual dosage is indicated in the insert. The drug should be kept in the tray, protected from light until use, and discarded if any unused portion exists. It should be stored under controlled room temperature of 20 to 25°C (68 to 77°F). The pack was distributed by Hospira of Lake Forest, Illinois, USA with FPO/10 Mil 0304091465012 and Lot # e-sss-sn.*

This is a description for a medication containing Nalbuphine HCI, a type of pain reliever. The medication comes in a multiple-dose container and must be protected from light. It is sterile and nonpyrogenic, and also contains sodium citrate, citric acid, methylparaben, propylparaben, and NaCl. It may contain NaOH and/or HCl to adjust pH. The medication is distributed by Hospira, Inc. for use via intravenous (IV), intramuscular (IM), or subcutaneous (SC) administration. The temperature for storage of the medication should be controlled between 15-30°C (59-77°F).*

This is a prescription drug, which comes in a flip-top vial and is available in a solution form. The solution is for intravenous, or subcutaneous use. Each mL of the solution contains nalbuphine HCI mixed with sodium citrate, citric acid, methyiparaben, propylparaben, and sodium chloride. It may contain NaOH and/or HCI to adjust pH. This is a multi-dose drug, which includes a cover for the flip-top vial. The drug should be stored at 20-25°C and protected from light. The usual dosage is not available, so it should only be used as directed by the physician.*

This is a description of a 10 mL multiple-dose nalbuphine HCI injection manufactured by Hospira, Inc. It is intended for V., LM., or S.C. use and is only available through a prescription. The medication contains 20mg of nalbuphine HCI, which is buffered with sodium citrate and citric acid, and preserved with methylparaben and propylparaben. The tonicity is adjusted with NaCl and the pH may contain NaOH and/or HCI. It is sterile, nonpyrogenic, and should be stored at 20 to 26°C. The lot number and expiration date are also provided.*

This is the description of a medication called Auoxy 184 doid3250p AN. It is a sterile, non-pyrogenic solution contained in a fliptop vial that can be used for intravenous, intramuscular or subcutaneous injection. Each milliliter of the solution contains 20 mg of nalbuphine HCI, as well as other ingredients such as sodium chorate, dihydrate, and clric aci, etc. The usual dosage should be seen in its insert. The medication must be protected from light and stored in a controlled room temperature range. It should be used with aseptic techniques, and the stopper of the vial must be cleansed with antiseptic before use. The medication is distributed by Hospira, Inc.*